Exabone GmbH, a Swiss startup founded in 2011, is strategically positioned within the burgeoning life science cluster of Western Switzerland. The company is dedicated to developing innovative biomaterials and surgical implants, with a primary focus on orthopaedic surgery. As an ISO 13485 certified company, Exabone GmbH operates within the Biotechnology and Medical Devices industries. The startup's dedication to pioneering medical solutions within a rapidly expanding market makes it an intriguing prospect for venture capital investment.
There is no investment information
No recent news or press coverage available for Exabone GmbH.
We care about your data, and we'd love to use cookies make your experience better.
